The overall goal of this program project is to discover and develop effective chemopreventative agents against lung and esophageal cancer, two important cancer types in the United States for which five year survival rates are very low. Our approach is to develop chemopreventative agents based on an understanding of the mechanisms by which they prevent tumor development. Under the support of the cooperative agreement that preceded this program project, we have established isothiocyanates are outstanding inhibitors of lung and esophageal cancer in animal models. The mechanisms of inhibition have ben elucidated and parallels between animals and humans noted. One compound developed by us-phenyl isothiocyanate (PEITC)-has been selected by NCI for phase I studies. In the current application, we will extend our studies on the development of isothiocyanates and their conjugates as chemopreventative agents for tobacco related cancers. Project 1, """"""""Conjugates of Isothiocyanates as Chemopreventive Agents"""""""" will focus on the development of these compounds for chemoprevention of lung cancer, and will elucidate the relevant mechanisms. Collaborative studies with Projects 2 and 3 will examine toxicity, metabolism, and efficacy of isothiocyanate conjugates. Project 2, """"""""Inhibitions of Esophageal Squamous Cell Carcinoma"""""""" will investigate the mechanisms by which isothiocyanates and their conjugates inhibit esophageal cancer and will discover suppressing agents to be used together with isothiocyanates. In collaboration with Projects 1 and 3, they will extend their exciting recent results on inhibition of N'-nitrosonornicotine induced esophageal carcinogenesis by 3-phenylpropyl isothiocyanate. Project 3, lung tumorigenesis by polycyclic aromatic hydrocarbons and the mechanisms by which mixtures of isothiocyanates inhibit lung tumor induction by tobacco smoke carcinogens in rodents; these studies will then be extended to humans who consume vegetables as sources of isothiocyanates. Project 3 will collaborate with Projects 1 and 2 in these studies. The Management Core will provide administrative, biostatistical, and advisory support to all projects. Our overall hypothesis is that isothiocyanates and their conjugates will decrease DNA damages by tobacco related carcinogens and will therefore by effective chemopreventive agents against lung and esophageal cancer.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
3P01CA046535-13S1
Application #
6225500
Study Section
Subcommittee G - Education (NCI)
Project Start
1987-09-10
Project End
2003-01-31
Budget Start
2000-02-01
Budget End
2001-01-31
Support Year
13
Fiscal Year
2000
Total Cost
$27,118
Indirect Cost
Name
University of Minnesota Twin Cities
Department
Type
Schools of Medicine
DUNS #
168559177
City
Minneapolis
State
MN
Country
United States
Zip Code
55455
Stoner, Gary D; Wang, Li-Shu; Chen, Tong (2007) Chemoprevention of esophageal squamous cell carcinoma. Toxicol Appl Pharmacol 224:337-49
Hudson, Tamaro S; Stoner, Gary D; Morse, Mark A et al. (2005) Comparison of phenethyl and 6-phenylhexyl isothiocyanate-induced toxicity in rat esophageal cell lines with and without glutathione depletion. Toxicol Lett 155:427-36
Liston, Beth W; Nines, Ronald; Carlton, Peter S et al. (2003) Perillyl alcohol as a chemopreventive agent in N-nitrosomethylbenzylamine-induced rat esophageal tumorigenesis. Cancer Res 63:2399-403
Gopalakrishnan, Rajaram; Gupta, Ashok; Carlton, Peter S et al. (2002) Functional role of cytochrome p-450 2a3 in N-nitrosomethylbenzylamine metabolism in rat esophagus. J Toxicol Environ Health A 65:1077-91
Carlton, Peter S; Gopalakrishnan, Rajaram; Gupta, Ashok et al. (2002) Piroxicam is an ineffective inhibitor of N-nitrosomethylbenzylamine-induced tumorigenesis in the rat esophagus. Cancer Res 62:4376-82
Gupta, A; Nines, R; Rodrigo, K A et al. (2001) Effects of dietary N-(4-hydroxyphenyl)retinamide on N-nitrosomethylbenzylamine metabolism and esophageal tumorigenesis in the Fischer 344 rat. J Natl Cancer Inst 93:990-8
Hudson, T S; Carlton, P S; Gupta, A et al. (2001) Investigation of the enhancement of N-nitrosomethylbenzylamine-induced esophageal tumorigenesis by 6-phenylhexyl isothiocyanate. Cancer Lett 162:19-26
Liston, B W; Gupta, A; Nines, R et al. (2001) Incidence and effects of Ha-ras codon 12 G-->A transition mutations in preneoplastic lesions induced by N-nitrosomethylbenzylamine in the rat esophagus. Mol Carcinog 32:1-8
Boone, C W; Stoner, G D; Bacus, J V et al. (2000) Chemoprevention with theaflavins of rat esophageal intraepithelial neoplasia quantitatively monitored by image tile analysis. Cancer Epidemiol Biomarkers Prev 9:1149-54
Chung, F L; Jiao, D; Getahun, S M et al. (1998) A urinary biomarker for uptake of dietary isothiocyanates in humans. Cancer Epidemiol Biomarkers Prev 7:103-8